SCHEMBL1368243

SCHEMBL1368243

COc1ccc2cc(C(=O)/C=C/c3ccc(Cl)cc3)c(=O)oc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 11/20 0.67
HDAC1 Q13547 2/20 0.65
HDAC3 O15379 1/20 0.65
HDAC2 Q92769 1/20 0.65
HDAC10 Q969S8 1/20 0.65
HDAC11 Q96DB2 1/20 0.65
HDAC8 Q9BY41 1/20 0.65
HDAC6 Q9UBN7 1/20 0.65
ABCG2 Q9UNQ0 2/20 0.61
ALDH1A1 P00352 4/20 0.59
GAA P10253 2/20 0.59
HPGD P15428 2/20 0.59
SLC16A3 O15427 1/20 0.59
KDM4E B2RXH2 3/20 0.58
RAB9A P51151 2/20 0.58
MEN1 O00255 1/20 0.58
PLIN1 O60240 1/20 0.58
LMNA P02545 1/20 0.58
MAPT P10636 1/20 0.58
PLIN5 Q00G26 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351320 1.00 MAOB (0.67) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL1368244 1.00 MAOB (0.67) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL1366720 0.93 MAOB (0.74) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL1366721 0.93 MAOB (0.74) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL1368330 0.93 MAOB (0.74) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL22331082 0.89 MAOB (0.66) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL22331085 0.89 MAOB (0.66) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL2030678 0.87 MAOB (0.71) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL29380546 0.87 MAOB (0.71) MAOBHDAC1HDAC3HDAC2HDAC10
SCHEMBL2030676 0.87 MAOB (0.71) MAOBHDAC1HDAC3HDAC2HDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAOB 2929/4885HDAC1 110/4885HDAC3 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.